AstraZeneca

NCT00309478

Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

NCT00309491

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

NCT00846976

Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate Cancer

NCT00657904

Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer

NCT00673205

(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer

NCT00672282

Casodex vs Placebo in Non-Metastatic Early Prostate Cancer

NCT00291759

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

NCT00300508

3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer

NCT00849030

ATAC - Arimidex, Tamoxifen Alone or in Combination

NCT00635713

Second Line Breast Cancer Trial

NCT00814125

ATAC - Endometrial Sub-Protocol

NCT00256737

Sopran - Omeprazole Treatment Versus Surgery

NCT00286117

ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years

NCT00784680

ATAC - Quality of Life Sub-Protocol

NCT00784862

ATAC - Pharmacokinetics (PK) Sub-Protocol

NCT00784940

ATAC - Bone Density Sub-Protocol

NCT00227318

TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial

NCT00241449

A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer

NCT00007657

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

NCT00634400

Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)

NCT00003906

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

NCT00003645

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

NCT00634309

Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)

NCT00634712

Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)

NCT00295646

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

NCT00654303

OLE Study to Evaluate Safety / Efficacy of ZD4522

NCT00654394

Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic Subjects

NCT00635973

Open-Label Extension of Other SZ1839 (Iressa) Trials

NCT00006048

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

NCT00006049

ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

NCT00034879

Iressa Expanded Access Program (EAP)

NCT00232661

PROACT - Pre-Operative Arimidex Compared To Tamoxifen

NCT00223171

Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers

NCT00150631

Danish Hypertension Prevention Project - DHYPP

NCT00241527

Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

NCT00223145

Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone

NCT00241540

Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

NCT00637182

Gynecomastia Extension Study

NCT00241514

Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

NCT00629928

Ulcer Prevention II

NCT00633412

A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only

NCT00633672

A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued

NCT00629512

Prevention of Gastric Ulcers

NCT00241553

Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

NCT00654537

STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges

NCT00130975

Candesartan in the Prevention of Relapsing Atrial Fibrillation

NCT00252733

Diabetic Retinopathy Candesartan Trials

NCT00038077

Reversal of Ventricular Remodeling With Toprol-XL

NCT00252694

DIabetic Retinopathy Candesartan Trials

NCT00252720

DIabetic Retinopathy Candesartan Trials.

NCT02670642

Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD

NCT00251927

Esomeprazole (NEXIUM) vs. Surgery

NCT00305422

Effect of Quetiapine on Negative Symptoms and Cognition

NCT00654407

Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia

NCT00657527

Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease

NCT00254774

Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling

NCT00039026

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea

NCT00379249

Rosuvastatin ORBITAL Germany

NCT00654602

48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety

NCT00034892

CAFE Comparison of Atypicals in First Episode of Psychosis

NCT00039013

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

NCT00653744

Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)

NCT00042458

Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control

NCT00254735

Quetiapine Augmentation in Severe Obsessive Compulsive Disorder

NCT00546520

Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)

NCT00035984

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus

NCT00654485

COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects

NCT00654173

Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR)

NCT00255502

307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects

NCT00255528

Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects

NCT00642187

New Version Pulmicort Turbuhaler USA Adults

NCT00646529

Long-Term Safety of Symbicort in Asthmatic Children - SAPLING

NCT00651547

Symbicort in Asthmatic Children - SEEDLING

NCT00652002

Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5

NCT00044668

Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination

NCT00225589

A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)

NCT00651651

Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5

NCT00060489

Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression

NCT00617747

Efficacy and Tolerability of Zolmitriptan Nasal Spray

NCT00621647

Seroquel- Agitation Associated With Dementia

NCT00654446

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

NCT01789957

Extension Study for 2993-112

NCT00654225

Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)

NCT00182039

POISE Trial: Perioperative Ischemic Evaluation Study

NCT00055731

Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse

NCT00107107

Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus

NCT00111540

Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes

NCT00240318

A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)

NCT00642161

New Version Pulmicort Turbuhaler USA Children

NCT00800800

Effects of Rosuvastatin on Aortic Stenosis Progression

NCT00251914

Nexium Dyspepsia/AST

NCT00251992

Nexium Dyspepsia/AST

NCT00240279

The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study

NCT00240331

AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)

NCT00430729

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. Ratio-Study. (BY217/M2-112)

NCT00239681

JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events

NCT00240292

Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines

NCT00163332

Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129)

NCT00626535

A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)

NCT00646009

Symbicort Onset of Action 2

NCT00108004

Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

NCT00163410

Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)

NCT00163527

Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)

NCT00242346

High Doses of Candesartan Cilexetil on the Reduction of Proteinuria

NCT00641680

Rhinocort Aqua Versus Placebo and Fluticasone Propionate

NCT00642122

Adults With Moderate to Severe Asthma

NCT00646321

Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT

NCT00646620

Symbicort Onset of Action 1

NCT00652392

Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM

NCT00653588

Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks

NCT00061022

Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

NCT00653965

Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)

NCT00336830

Improving Cardiac Rehabilitation Participation in Women and Men

NCT00062582

Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)

NCT00082381

Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin

NCT00119626

Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

NCT00239330

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

NCT00241488

DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia

NCT00642096

Factorial Study of Metoprolol Succinate TOPROL-XL (324A)

NCT00221468

A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents

NCT00242801

Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study

NCT00449397

Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis

NCT00077948

Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure

NCT00065325

The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer

NCT00240266

Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)

NCT00651768

Titratable Dosing in Moderate to Severe Asthmatics

NCT00163345

Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131)

NCT00163358

Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)

NCT00206310

Crestor Versus Placebo in Subjects With Heart Failure

NCT00235911

Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting

NCT00244595

Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age

NCT00244634

Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age

NCT00252707

Iressa 2nd Line Phase III Study in Japan

NCT00193596

Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site

NCT00259077

Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

NCT00328978

Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects

NCT00646516

Gemini Symbicort pMDI

NCT00073177

Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)

NCT00079833

Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome

NCT00082407

Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin

NCT00206219

Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)

NCT00329173

PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.

NCT00646594

Atlantis Symbicort

NCT00076076

The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)

NCT00076089

OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)

NCT00163501

Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

NCT00214630

LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

NCT00233610

Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer

NCT00659750

To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)

NCT00659841

To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)

NCT01876849

An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus

NCT00163384

Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136)

NCT00163397

Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137)

NCT00232648

Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma

NCT00234468

Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

NCT00256698

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

NCT00259051

A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

NCT00114816

Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer

NCT00076388

Iressa Versus Docetaxel (Taxotere)

NCT00228514

Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study

NCT00241501

Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients

NCT00277667

Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms

NCT00295620

Secondary Adjuvant Long Term Study With Arimidex

NCT00081380

Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

NCT00107731

Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

NCT00240305

A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome

NCT00259766

SHARE - Symbicort and Health Economics in a Real Life Evaluation

NCT00099320

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

NCT00163475

Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)

NCT00163514

Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)

NCT00238784

SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults

NCT00251901

Chest Pain Pilot Study

NCT00251966

ASTERIX: Low Dose ASA and Nexium

NCT00083954

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

NCT00085891

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

NCT00653445

Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg

NCT00196859

Study in Elderly Patients With Early Breast Cancer (ICE)

NCT00252226

Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders

NCT00090311

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania

NCT00251940

GALLANT 7 Tesaglitazar Add-on to Sulphonylurea

NCT00251953

GALLANT 8 Tesaglitazar Add-on to Metformin

NCT00180076

Budesonide for Maintenance Treatment of Collagenous Colitis

NCT00214565

GALLANT 6 Tesaglitazar vs. Pioglitazone

NCT00214591

GALLANT 5 Tesaglitazar Versus Metformin

NCT00227305

Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder

NCT00242372

GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin

NCT00304473

Fast Titration in the Treatment of Schizophrenia, Taiwan

NCT00090324

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia

NCT00097500

Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes

NCT00099619

Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy

NCT00252772

GALLANT 2 Tesaglitazar vs. Placebo

NCT00255541

GALLANT 4 Tesaglitazar vs. Glibenclamide

NCT00259792

SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults

NCT00658918

To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)

NCT00139165

Long-Term Treatment of Collagenous Colitis With Budesonide

NCT00108823

The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121)

NCT00163462

Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)

NCT00254813

Fast Titration Of Quetiapine Versus Currently Approved Titration

NCT00288379

SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma

NCT00163319

Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)

NCT00163423

Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142)

NCT00206115

SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia

NCT00206128

Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia

NCT00234377

Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia

NCT00244621

Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age

NCT00659594

Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406)

NCT00246922

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)

NCT00252863

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00290264

SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma

NCT00306540

Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder

NCT00659048

Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)

NCT00163293

Efficacy of Ciclesonide Inhaled Once Daily Versus Other Corticosteroids Used for Treatment of Mild Asthma in Children (4 to 11 Years) (BY9010/CA-101)

NCT00163488

Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)

NCT00357734

Iressa Follow-up Trial

NCT00099437

Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

NCT00214604

Type III Dysbetalipoproteinemia

NCT00229710

GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes

NCT00659503

Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407)

NCT00357682

A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia

NCT00226330

GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus

NCT00228462

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

NCT00252876

GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes

NCT00261352

GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate

NCT00314184

Quetiapine Fumarate Bipolar Maintenance Monotherapy

NCT00206154

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients

NCT00206167

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD

NCT00243724

HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease

NCT00252837

GALLANT 22 Tesaglitazar vs. Placebo

NCT00119652

Seroquel in Bipolar Depression Versus SSRI

NCT00242775

Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg

NCT00244608

A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®

NCT00246935

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)

NCT00122070

Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder

NCT00120003

Scandinavian Candesartan Acute Stroke Trial (SCAST)

NCT00121641

Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

NCT00252824

STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma

NCT00121667

Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone

NCT00206141

Seroquel in Bipolar Depression Versus Lithium

NCT00242320

Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)

NCT00448578

Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder Patients

NCT00174603

Treatment of Depression With Quetiapine

NCT00206440

Nexium Study To Suppress Nausea During Chemotherapy

NCT00163371

Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208)